Navigation Links
Medbox and AVT Develop Secure, Automated Medicine Sample Dispenser for Doctor's Offices

CORONA, Calif., Aug. 19, 2013 /PRNewswire/ -- AVT, Inc. (OTC Markets: AVTC) (, a technology leader in developing automated retailing systems, customized kiosks and micro-stores; and Medbox, Inc. (OTC Markets: MDBX) (, a leader in providing consulting services and patented systems to the medical and retail industries, jointly announced the development of a new system that will improve the process of storing and dispensing prescription medicine samples in doctor's offices nationwide.

The Medbox "Sample Safe" was developed for Medbox by AVT, based on Medbox's patent pending design, and is for use in doctor's offices where samples of prescription medications are commonly misappropriated or not tracked. The unit offers precise inventory control through the use of biometric identification security, and an unalterable internal record keeping system.

According to the IMS Market Prognosis Report, the global spending on prescription drugs topped $954 billion. United States accounts for almost half of the global pharmaceutical market, with $340 billion in annual sales, followed by the EU and Japan.

"Our partnership with Medbox has proved to be profitable for both companies," said Shannon Illingworth, Chairman and Founder of AVT, Inc. "We enjoy collaborating with them on new ideas, and now we have developed a remarkable system for Medbox that will gain us entry into the $25 billion market of medicine marketing," he added.

There are approximately 230,187 physician practices in the United States. That's more than the total number of grocery stores and McDonald's restaurants combined.

"The market is huge," said James Winsor, CEO of AVT. "Even a 1% market share is worth over $20 million in sales," he added. "And we think we will do much better than that."

"Imagine if you are a pharmaceutical company representative, and now you can get an automatic text message directly from the Medbox Sample Safe machine when it is getting low on samples," Vincent Mehdizadeh, COO of Medbox commented. "We are HIPAA compliant, yet can give the pharmaceutical companies valuable demographic data on who is using their medications," he added.

The Medbox Sample Safe will not only allow pharmaceutical companies to better tailor the types of samples they provide to doctor's offices and streamline their rep's schedule of office visits, but will also reduce theft and abuse, increase transparency and compliance, and provide high-value data.

Doctor's offices benefit from the Medbox Sample Safe because it keeps items secure and provides an unalterable log of medication dispensing. Tracking and monitoring samples has been a challenge for many physicians, prompting many to stop stocking the medications.

"We haven't always done as good a job as we should in monitoring and tracking and keeping close tabs on the inventory of samples that we have," said David Maizel, MD, president of Sentara Medical Group in an article published in American Medical News. "For us to really be in compliance requires a significant administrative effort. For instance, if we got a recall notice from a manufacturer, we'd have to be able to identify the affected samples by lot number, expiration date and so on. We don't have anything other than a manual process for that now."

"The Medbox Sample Safe solves a lot of problems, and increases safety, reporting, and compliance," Mehdizadeh commented. "We anticipate making a significant impact on this market."

Medbox has already contracted with AVT for the first wave of sample-safe units that will be the demonstration models for pharmaceutical companies to see the system, up-close and personal.  

For more information on AVT, visit the website at:, or call (877) 424-3663.

For more information on Medbox, visit:

To read the IMS Report, visit:

To read the report on pharmaceutical marketing, visit: 

To read the article in American Medical News, visit:

To view the supermarket facts, go to:

For Media Only: Interview requests and more information can be obtained by contacting The Innovation Agency, at: hello(@)

About AVT, Inc:

AVT is a leading developer of customized automated retailing systems, Micro-Stores, and self-service solutions.  Divisions include design, manufacturing, software engineering, leasing, media, and technology licensing. AVT is able to work with any size company to design a custom automated retailing solution that drives traffic, increases sales, improves security, and lowers overhead. AVT is uniquely qualified to take projects from concept to completion with speed, economy and ingenuity. For more information, visit:

AVT's stock is traded through the OTC Markets, Ticker Symbol: AVTC

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws.  Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control.  In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change.  Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation.  We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
2. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
3. Medbox, Inc. To Support Referendum Overturning LA City Council Ban on Medical Marijuana Outlets
4. Medbox, Inc. at the Forefront of Providing Secure Medicine Dispensing Systems to Prisons
5. Medbox Announces Increase in Shareholder Base and Record Revenue Generated in Q3
6. Medbox, Inc. Protects Its Image as a Leader in Sensible Medication Dispensing
7. Medbox Inc. Featured in Wall Street Journal
8. Medbox Responds to Unprecedented Rise in Stock Price
9. Medbox Updates Financial Projections
10. Medbox, Inc. Offers Guidance and Consultation To Washington State
11. Medbox, Inc. Commences Pursuit of Strategic Acquisitions
Post Your Comments:
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):